share_log

GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F

SEC announcement ·  Mar 5 13:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more